Table of Content

1 Research Methodology

2 Research Objectives

3 Research Process


4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation By Product
4.3.2 Market Segmentation By Usage
4.3.3 Market Segmentation By Distribution Channels
4.3.4 Market Segmentation By End-Users
4.3.5 Market Segmentation By Geography


5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation


6 Market At A Glance


7 Introduction
7.1 Overview
7.1.1 Importance Of Blood Glucose Testing


8 Market Opportunities & Trends
8.1 Increase In Diabetic Population
8.2 Covid-19 Pandemic Boosts Demand For Self-Monitoring Glucose Devices
8.3 Emergency Of Non-Invasive Blood Glucose Monitoring Devices


9 Market Growth Enablers
9.1 Technological Advances In Blood Glucose Monitoring
9.2 New Product Launches
9.3 Availability Of Mobile Applications & Data Integration Platforms


10 Market Restraints
10.1 Limitations Associated With BGM Devices
10.2 Large Pool Of Undiagnosed People
10.3 High Cost Of Blood Glucose Monitoring Devices

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat Of New Entrants
11.3.2 Bargaining Power Of Suppliers
11.3.3 Bargaining Power Of Buyers
11.3.4 Threat Of Substitutes
11.3.5 Competitive Rivalry


12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview


13 Conventional Blood Glucose Monitoring
13.1 Market Overview
13.2 Market Size & Forecast
13.3 Conventional Blood Glucose Monitoring: Geography Segmentation
13.3.1 Market Snapshot & Growth Engine
13.3.2 Market by Geography
13.3.3 Market Snapshot & Growth Engine
13.4 Test Strips
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Test Strips: Geography Segmentation
13.4.4 Market by Geography
13.5 Lancets & Lancing Devices
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Lancets & Lancing Devices: Geography Segmentation
13.5.4 Market by Geography
13.6 Meters & Software
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Meters & Softwares: Geography Segmentation
13.6.4 Market by Geography


14 Continuous Blood Glucose Monitoring Devices
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Market Snapshot & Growth Engine
14.4 Sensors
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Sensors: Geography Segmentation
14.4.4 Market by Geography
14.5 Reusable Hardwares
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Reusable Hardwares: Geography Segmentation
14.5.4 Market By Geography


15 Usage
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Personal BGM
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Personal BGM: Geography Segmentation
15.3.4 Market By Geography
15.4 Professional BGM
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Professional BGM: Geography Segmentation
15.4.4 Market By Geography


16 Distribution Channel
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Online Stores
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Online Stores: Geography Segmentation
16.3.4 Market By Geography
16.4 Offline Stores
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Offline Stores: Geography Segmentation
16.4.4 Market By Geography


17 End-User
17.1 Market Snapshot & Growth Engine
17.2 Market Overview
17.3 Individuals
17.3.1 Market Overview
17.3.2 Market Size & Forecast
17.3.3 Individuals: Geography Segmentation
17.3.4 Market By Geography
17.4 Hospitals & Clinics
17.4.1 Market Overview
17.4.2 Market Size & Forecast
17.4.3 Hospitals & Clinics: Geography Segmentation
17.4.4 Market By Geography
17.5 Others
17.5.1 Market Overview
17.5.2 Market Size & Forecast
17.5.3 Others: Geography Segmentation
17.5.4 Market By Geography


18 Geography
18.1 Market Snapshot & Growth Engine
18.2 Geographic Overview


19 North America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 North America: Product Segmentation
19.3.1 Market Snapshot & Growth Engine
19.4 North America: Conventional Glucose Monitoring Segmentation
19.4.1 Market Snapshot & Growth Engine
19.5 North America: Continuous Glucose Monitoring Segmentation
19.5.1 Market Snapshot & Growth Engine
19.6 North America: Usage Segmentation
19.6.1 Market Snapshot & Growth Engine
19.7 North America: End-User Segmentation
19.7.1 Market Snapshot & Growth Engine
19.8 North America: Distribution Segmentation
19.8.1 Market Snapshot & Growth Engine
19.9 Key Countries
19.9.1 US: Market Size & Forecast
19.9.2 Canada: Market Size & Forecast


20 Europe
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Europe: Product Segmentation
20.3.1 Market Snapshot & Growth Engine
20.4 Europe: Conventional Glucose Monitoring Segmentation
20.4.1 Market Snapshot & Growth Engine
20.5 Europe: Continuous Glucose Monitoring Segmentation
20.5.1 Market Snapshot & Growth Engine
20.6 Europe: Usage Segmentation
20.6.1 Market Snapshot & Growth Engine
20.7 Europe: End-User Segmentation
20.7.1 Market Snapshot & Growth Engine
20.8 Europe: Distribution Segmentation
20.8.1 Market Snapshot & Growth Engine
20.9 Key Countries
20.9.1 Germany: Market Size & Forecast
20.9.2 France: Market Size & Forecast
20.9.3 UK: Market Size & Forecast
20.9.4 Italy: Market Size & Forecast
20.9.5 Spain: Market Size & Forecast


21 APAC
21.1 Market Overview
21.2 Market Size & Forecast
21.3 APAC: Product Segmentation
21.3.1 Market Snapshot & Growth Engine
21.4 APAC: Conventional Glucose Monitoring Segmentation
21.4.1 Market Snapshot & Growth Engine
21.5 APAC: Continuous Glucose Monitoring Segmentation
21.5.1 Market Snapshot & Growth Engine
21.6 APAC: Usage Segmentation
21.6.1 Market Snapshot & Growth Engine
21.7 APAC: End-User Segmentation
21.7.1 Market Snapshot & Growth Engine
21.8 APAC: Distribution Segmentation
21.8.1 Market Snapshot & Growth Engine
21.9 Key Countries
21.9.1 China: Market Size & Forecast
21.9.2 Japan: Market Size & Forecast
21.9.3 India: Market Size & Forecast
21.9.4 South Korea: Market Size & Forecast
21.9.5 Australia: Market Size & Forecast

22 Latin America
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Latin America: Product Segmentation
22.3.1 Market Snapshot & Growth Engine
22.4 Latin America: Conventional Glucose Monitoring Segmentation
22.4.1 Market Snapshot & Growth Engine
22.5 Latin America: Continuous Glucose Monitoring Segmentation
22.5.1 Market Snapshot & Growth Engine
22.6 Latin America: Usage Segmentation
22.6.1 Market Snapshot & Growth Engine
22.7 Latin America: End-User Segmentation
22.7.1 Market Snapshot & Growth Engine
22.8 Latin America: Distribution Segmentation
22.8.1 Market Snapshot & Growth Engine
22.9 Key Countries
22.9.1 Brazil: Market Size & Forecast
22.9.2 Mexico: Market Size & Forecast
22.9.3 Colombia: Market Size & Forecast
22.9.4 Argentina: Market Size & Forecast

23 Middle East And Africa
23.1 Market Overview
23.2 Market Size & Forecast
23.3 Middle East And Africa: Product Segmentation
23.3.1 Market Snapshot & Growth Engine
23.4 Middle East And Africa: Conventional Glucose Monitoring Segmentation
23.4.1 Market Snapshot & Growth Engine
23.5 Middle East And Africa: Continuous Glucose Monitoring Segmentation
23.5.1 Market Snapshot & Growth Engine
23.6 Middle East And Africa: Usage Segmentation
23.6.1 Market Snapshot & Growth Engine
23.7 Middle East And Africa: End-User Segmentation
23.7.1 Market Snapshot & Growth Engine
23.8 Middle East And Africa: Distribution Segmentation
23.8.1 Market Snapshot & Growth Engine
23.9 Key Countries
23.9.1 Turkey: Market Size & Forecast
23.9.2 South Africa: Market Size & Forecast
23.9.3 Saudi Arabia: Market Size & Forecast
23.9.4 Iran: Market Size & Forecast

24 Competitive Landscape
24.1 Competition Overview
24.2 Market Share Analysis
24.2.1 F. Hoffmann-La Roche
24.2.2 Abbott
24.2.3 Dexcom
24.2.4 Ascensia
24.2.5 Medtronic
24.2.6 Lifescan

25 Key Company Profiles
25.1 Abbott
25.1.1 Business Overview
25.1.2 Product Offerings
25.1.3 Key Strategies
25.1.4 Key Strengths
25.1.5 Key Opportunities
25.2 F. Hoffmann-La Roche
25.2.1 Business Overview
25.2.2 Product Offerings
25.2.3 Key Strategies
25.2.4 Key Strengths
25.2.5 Key Opportunities
25.3 DEXCOM
25.3.1 Business Overview
25.3.2 Product Offerings
25.3.3 Key Strategies
25.3.4 Key Strengths
25.3.5 Key Opportunities
25.4 Medtronic
25.4.1 Business Overview
25.4.2 Product Offerings
25.4.3 Key Strategies
25.4.4 Key Strengths
25.4.5 Key Opportunities
25.5 Ascensia Diabetes Care Holdings
25.5.1 Business Overview
25.5.2 Product Offerings
25.5.3 Key Strategies
25.5.4 Key Strengths
25.5.5 Key Opportunities
25.6 Lifescan
25.6.1 Business Overview
25.6.2 Product Offerings
25.6.3 Key Strategies
25.6.4 Key Strengths
25.6.5 Key Opportunities


26 Other Prominent Vendors
26.1 77 ELEKTRONIKA KFT
26.1.1 Business Overview
26.1.2 Product Offerings
26.2 A. Menarini Diagnostics
26.2.1 Business Overview
26.2.2 Product Offerings
26.3 Arkray
26.3.1 Business Overview
26.3.2 Product Offerings
26.4 Apexbio
26.4.1 Business Overview
26.4.2 Product Offerings
26.5 ACON
26.5.1 Business Overview
26.5.2 Product Offerings
26.6 AGAMATRIX
26.6.1 Business Overview
26.6.2 Product Offerings
26.7 Alliance International
26.7.1 Business Overview
26.7.2 Product Offerings
26.8 Andon Health (TIANJIN JIU’AN MEDICAL ELECTRONICS)
26.8.1 Business Overview
26.8.2 Product Offerings
26.9 B.Braun Melsungen
26.9.1 Business Overview
26.9.2 Product Offerings
26.10 BIONIME
26.10.1 Business Overview
26.10.2 Product Offerings
26.11 BEURER
26.11.1 Business Overview
26.11.2 Product Offerings
26.12 BIOPTIK
26.12.1 Business Overview
26.12.2 Product Offerings
26.13 Biotelemetry
26.13.1 Business Overview
26.13.2 Product Offerings
26.14 Biotest Medical
26.14.1 Business Overview
26.14.2 Product Offerings
26.15 BTNX
26.15.1 Business Overview
26.15.2 Product Offerings
26.16 Dariohealth
26.16.1 Business Overview
26.16.2 Product Offerings
26.17 Easymax
26.17.1 Business Overview
26.17.2 Product Offerings
26.18 Foracare
26.18.1 Business Overview
26.18.2 Product Offerings
26.19 Hannox International
26.19.1 Business Overview
26.19.2 Product Offerings
26.20 Integrity Applications
26.20.1 Business Overview
26.20.2 Product Offerings
26.21 I-SENS
26.21.1 Business Overview
26.21.2 Product Offerings
26.22 MED Trust
26.22.1 Business Overview
26.22.2 Product Offerings
26.23 Medisana
26.23.1 Business Overview
26.23.2 Product Offerings
26.24 Medtrum Technologies
26.24.1 Business Overview
26.24.2 Product Offerings
26.25 Nova Biomedical
26.25.1 Business Overview
26.25.2 Product Offerings
26.26 Omnis Health
26.26.1 Business Overview
26.26.2 Product Offerings
26.27 Nemaura
26.27.1 Business Overview
26.27.2 Product Offerings
26.28 OK Biotech
26.28.1 Business Overview
26.28.2 Product Offerings
26.29 OSANG Healthcare
26.29.1 Business Overview
26.29.2 Product Offerings
26.3 PHILOSYS
26.30.1 Business Overview
26.30.2 Product Offerings
26.31 SANOFI
26.31.1 Business Overview
26.31.2 Product Offerings
26.32 Taidoc Technology
26.32.1 Business Overview
26.32.2 Product Offerings
26.33 TERUMO
26.33.1 Business Overview
26.33.2 Product Offerings
26.34 Trividia Health
26.34.1 Business Overview
26.34.2 Product Offerings
26.35 Rossmax International
26.35.1 Business Overview
26.35.2 Product Offerings
26.36 YPSOMED
26.36.1 Business Overview
26.36.2 Product Offerings


27 Report Summary
27.1 Key Takeaways
27.2 Strategic Recommendations


28 Quantitative Summary
28.1 Market By Geography
28.2 Market By Product
28.2.1 North America: Product Segmentation
28.2.2 Europe: Product Segmentation
28.2.3 APAC Product Segmentation
28.2.4 Latin America: Product Segmentation
28.2.5 Middle East And Africa: Product Segmentation
28.3 Market By End-User
28.3.1 Blood Glucose Monitoring Devices – Individuals By Geography
28.3.2 Blood Glucose Monitoring Devices – Hospitals & Clinics By Geography
28.3.3 Blood Glucose Monitoring Devices – Others By Geography
28.3.4 North America: End-User Segmentation
28.3.5 Europe: End-User Segmentation
28.3.6 APAC: End-User Segmentation
28.3.7 Latin America: Product Segmentation
28.3.8 Middle East & Africa: End-User Segmentation
28.4 Market By Usage
28.4.1 Blood Glucose Monitoring Devices – Personal By Geography
28.4.2 Blood Glucose Monitoring Devices – Professional By Geography
28.4.3 North America: Usage Segmentation
28.4.4 Europe : Usage Segmentation
28.4.5 APAC : Usage Segmentation
28.4.6 Latin America: Usage Segmentation
28.4.7 Middle East & Africa : Usage Segmentation
28.5 Market By Distribution Channel
28.5.1 Blood Glucose Monitoring Devices – Offline By Geography
28.5.2 Blood Glucose Monitoring Devices – Online By Geography
28.5.3 North America: Distribution Segmentation
28.5.4 Europe : Distribution Segmentation
28.5.5 APAC : Distribution Segmentation
28.5.6 Latin America: Distribution Segmentation
28.5.7 Middle East & Africa : Distribution Segmentation


29 Appendix
29.1 Abbreviations